175 related articles for article (PubMed ID: 22560837)
1. Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels-Alder reaction.
Ji C; Lin W; Moraski GC; Thanassi JA; Pucci MJ; Franzblau SG; Möllmann U; Miller MJ
Bioorg Med Chem; 2012 Jun; 20(11):3422-8. PubMed ID: 22560837
[TBL] [Abstract][Full Text] [Related]
2. Novel and potent oxazolidinone antibacterials featuring 3-indolylglyoxamide substituents.
Takhi M; Singh G; Murugan C; Thaplyyal N; Maitra S; Bhaskarreddy KM; Amarnath PV; Mallik A; Harisudan T; Trivedi RK; Sreenivas K; Selvakumar N; Iqbal J
Bioorg Med Chem Lett; 2008 Sep; 18(18):5150-5. PubMed ID: 18768315
[TBL] [Abstract][Full Text] [Related]
3. An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria.
Kaushik A; Heuer AM; Bell DT; Culhane JC; Ebner DC; Parrish N; Ippoliti JT; Lamichhane G
Bioorg Med Chem Lett; 2016 Aug; 26(15):3572-6. PubMed ID: 27329794
[TBL] [Abstract][Full Text] [Related]
4. Novel Mannich ketones of oxazolidinones as antibacterial agents.
Srivastava BK; Kapadnis PB; Pandya P; Lohray VB
Eur J Med Chem; 2004 Nov; 39(11):989-92. PubMed ID: 15501548
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria.
Oh SH; Kim J; Baek SY; Chae SE; Park HS; Cho YL; Kwak JH
Molecules; 2017 Mar; 22(3):. PubMed ID: 28273820
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial activity of some aryloxy/thioaryloxy oxazolidinone derivatives.
Arora V; Salunkhe MM; Sinha N; Sinha RK; Jain S
Bioorg Med Chem Lett; 2004 Sep; 14(18):4647-50. PubMed ID: 15324881
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of spiropyrimidinetriones oxazolidinone derivatives as antibacterial agents.
Siddiqui AM; Sattigeri JA; Javed K; Shafi S; Shamim M; Singhal S; Malik ZM
Bioorg Med Chem Lett; 2018 Apr; 28(7):1198-1206. PubMed ID: 29525219
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of a series of alpha-substituted acetylpiperazinyl oxazolidinones.
Wang XJ; Du GJ; Zhao SQ; Yan M; Gu LQ
Chem Biol Drug Des; 2009 Sep; 74(3):276-81. PubMed ID: 19703029
[TBL] [Abstract][Full Text] [Related]
9. Syntheses and antibacterial activity studies of new oxazolidinones from nitroso Diels-Alder chemistry.
Yan S; Miller MJ; Wencewicz TA; Möllmann U
Bioorg Med Chem Lett; 2010 Feb; 20(3):1302-5. PubMed ID: 20031407
[TBL] [Abstract][Full Text] [Related]
10. Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent.
Lohray BB; Lohray VB; Srivastava BK; Kapadnis PB; Pandya P
Bioorg Med Chem; 2004 Sep; 12(17):4557-64. PubMed ID: 15358283
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antibacterial activity of 5-substituted oxazolidinones.
Phillips OA; Udo EE; Ali AA; Al-Hassawi N
Bioorg Med Chem; 2003 Jan; 11(1):35-41. PubMed ID: 12467705
[TBL] [Abstract][Full Text] [Related]
12. Novel piperidinyloxy oxazolidinone antimicrobial agents.
Weidner-Wells MA; Boggs CM; Foleno BD; Wira E; Bush K; Goldschmidt RM; Hlasta DJ
Bioorg Med Chem Lett; 2001 Jul; 11(14):1829-32. PubMed ID: 11459641
[TBL] [Abstract][Full Text] [Related]
13. Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones.
Renslo AR; Jaishankar P; Venkatachalam R; Hackbarth C; Lopez S; Patel DV; Gordeev MF
J Med Chem; 2005 Jul; 48(15):5009-24. PubMed ID: 16033280
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and combinational antibacterial study of 5''-modified neomycin.
Zhang J; Keller K; Takemoto JY; Bensaci M; Litke A; Czyryca PG; Chang CW
J Antibiot (Tokyo); 2009 Oct; 62(10):539-44. PubMed ID: 19629142
[TBL] [Abstract][Full Text] [Related]
15. Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials.
Lohray BB; Lohray VB; Srivastava BK; Gupta S; Solanki M; Pandya P; Kapadnis P
Bioorg Med Chem Lett; 2006 Mar; 16(6):1557-61. PubMed ID: 16386420
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
Shaw KJ; Poppe S; Schaadt R; Brown-Driver V; Finn J; Pillar CM; Shinabarger D; Zurenko G
Antimicrob Agents Chemother; 2008 Dec; 52(12):4442-7. PubMed ID: 18838596
[TBL] [Abstract][Full Text] [Related]
17. Novel oxazolidinone-quinolone hybrid antimicrobials.
Gordeev MF; Hackbarth C; Barbachyn MR; Banitt LS; Gage JR; Luehr GW; Gomez M; Trias J; Morin SE; Zurenko GE; Parker CN; Evans JM; White RJ; Patel DV
Bioorg Med Chem Lett; 2003 Dec; 13(23):4213-6. PubMed ID: 14623004
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro evaluation of substituted phenyl-piperazinyl-phenyl oxazolidinones against Gram-positive bacteria.
Liu J; He B; Yu A; Zhou W
Chem Biol Drug Des; 2007 Apr; 69(4):265-8. PubMed ID: 17461974
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci, and selected gram-negative organisms.
Sweeney MT; Zurenko GE
Antimicrob Agents Chemother; 2003 Jun; 47(6):1902-6. PubMed ID: 12760865
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of 2-(2',4'-dibromophenoxy)-4,6-dibromophenol from Dysidea granulosa.
Shridhar DM; Mahajan GB; Kamat VP; Naik CG; Parab RR; Thakur NR; Mishra PD
Mar Drugs; 2009 Sep; 7(3):464-71. PubMed ID: 19841726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
